FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileApollomics, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
APLMW
Apollomics, Inc. Stock AnalysisComprehensive stock analysis for Apollomics, Inc. (APLMW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAPLMW
APLMW
Apollomics, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
APLMW
  1. Home
  2. Stocks
  3. Apollomics, Inc.

Apollomics, Inc.

🇺🇸APLMW•NASDAQ

Apollomics, Inc.

🇺🇸APLMW•NASDAQ
Market cap
$147.80M

Your view on APLMW

Mkt Cap
$147.80M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Apollomics, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Hung-Wen Chen
Headquarters
989 East Hillsdale Blvd, Foster City, CA, US
Industry
Biotechnology
Sector
Healthcare
CEO
Hung-Wen Chen
Headquarters
989 East Hillsdale Blvd, Foster City, CA, US
Description

Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Apollomics, Inc.. Starting points for Apollomics, Inc.: EPS -$3.32, beta 2.09 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Apollomics, Inc.. Trailing twelve-month EPS for Apollomics, Inc. stands at -$3.32. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate−$122.00−$138.00
Lowest estimate−$122.00−$138.00
Highest estimate−$122.00−$138.00
Number of analysts11
A year ago−$7.571—
Growth vs a year ago——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$237164.00$370045.00
Lowest estimate$237164.00$370045.00
Highest estimate$237164.00$370045.00
Number of analysts11
A year ago$8.50M—
Growth vs a year ago−97.2%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Apollomics, Inc.. Apollomics, Inc. has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold APLMW17 companies
Compare APLMW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
AQFDClick To Raffle.Com, Inc.Financial ServicesFinancial - Conglomerates$3,024
IMMGImmage Biotherapeutics Corp.Financial ServicesFinancial - Conglomerates$15,174
KCPCKey Capital CorporationFinancial ServicesFinancial - Conglomerates$4,602
PGIEPGI Energy, Inc.EnergyOil & Gas Midstream$20,222
PLMKPlum Acquisition Corp. IVFinancial ServicesShell Companies$258.2M
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
BETRFBetterLife Pharma Inc.HealthcareOTC$6.4M
BHVNBiohaven Ltd.HealthcareNYSE$1.9B
BICTFBiocure Technology Inc.HealthcareOTC$379,088
BIOABioAge Labs, Inc.HealthcareNASDAQ$161.1M
BIOAFBioasis Technologies Inc.HealthcareOTC$15,883
BIORQBiora Therapeutics, Inc.HealthcarePNK—
BIT.AXBiotron LimitedHealthcareASX—
BITRFBiotron LimitedHealthcareOTC$29.2M
BIVIBioVie Inc.HealthcareNASDAQ$8.6M
BIXTBioxytran, Inc.HealthcareOTC$3.6M
BLAB.CNBritannia Life Sciences Inc.HealthcareCNQ$13.0M
BLEGBranded Legacy IncHealthcareOTC$542,622
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Apollomics, Inc., and how their positions are changing. At a $147.8M market value, institutional positions materially move Apollomics, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Apollomics, Inc. executives and directors. Shares of Apollomics, Inc. have traded between $0.01 and $0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Apollomics, Inc.

APLMW AnalysisWeak
Past
1
Growth
5
Health
1
Profit
1
Value
1